A detailed history of Capital Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 3,908 shares of NVO stock, worth $535,396. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,908
Previous 3,210 21.74%
Holding current value
$535,396
Previous $412,000 35.19%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $85,651 - $102,543
698 Added 21.74%
3,908 $557,000
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $85,466 - $113,765
837 Added 35.27%
3,210 $412,000
Q4 2023

Jan 05, 2024

SELL
$87.78 - $105.45 $5,705 - $6,854
-65 Reduced 2.67%
2,373 $245,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $221,711 - $486,478
2,438 New
2,438 $221,000
Q4 2022

Jan 05, 2023

BUY
$102.55 - $135.33 $198,229 - $261,592
1,933 New
1,933 $262,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.